A two-year study of the new cyclosporine formulation Consupren in de novo renal transplant patients.
Stephan
A G
AG
Rizk Hospital, Beirut, Lebanon.
Barbari
A
A
Masri
M
M
Kamel
G
G
Barakat Khoury
W
W
Karam
A
A
Mokhbat
J
J
Kilany
H
H
D000284:Administration, Oral; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004304:Dosage Forms; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D013997:Time Factors
D004304:Dosage Forms; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine